查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813791

人工心臟瓣膜市场规模、份额和趋势分析报告：按瓣膜、材料、最终用途、地区和细分市场预测，2025-2033 年

Prosthetic Heart Valve Market Size, Share & Trends Analysis Report By Valve (Transcatheter Heart Valves, Bioprosthetic Valves, Mechanical Valves), By Material, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

人工心臟瓣膜市场摘要

2024 年全球人工心臟瓣膜市场价值估计为 96.4 亿美元，预计 2033 年将达到 206.9 亿美元，2025 年至 2033 年的复合年增长率为 8.7%。

心臟瓣膜疾病数量的增加推动了市场的成长

根据 2024 年 12 月发表的 NCBI 论文，最近的估计表明，约有 5,480 万人患有风湿性心臟疾病(RHD)，置信区间为 4,330 万至 6,760 万。此外，非风湿性钙化性主动脉瓣疾病 (CAVD) 影响全球约 1,330 万人，而非风湿性退化性二尖瓣疾病 (DMVD) 约占全球病例的 1,550 万人。这些疾病是结构性瓣膜功能障碍的主要原因之一，通常需要手术或经导管瓣膜置换术。此外，风湿性和退化性瓣膜疾病在不同年龄层和地区的盛行率高且不断上升是推动市场扩张的关键因素。

心臟瓣膜疾病的发生率不断上升，尤其是在老年人中，这是人工心臟瓣膜置换术（包括手术和经导管方法）广泛应用的一个主要因素。主动脉瓣狭窄和二尖瓣瓣膜闭锁不全等退化性疾病日益普遍，推动了对人工瓣膜植入等有效干预措施的需求。根据 2024 年 CDC 的一份报告，四分之三的美国成年人对心臟瓣膜疾病的认识较低，尤其是 65 岁及以上的人。每年有超过 500 万美国人被诊断出患有心臟瓣膜疾病，每年导致超过 25,000 人死亡。这些数字凸显了加强教育、早期诊断和扩大人工心臟瓣膜治疗机会的迫切需求。

政府资助和宣传宣传活动正在推动人工心臟瓣膜产业的发展。根据美国心臟协会（美国 Heart Association, Inc.）2024年10月发表的报导，美国疾病管制与预防中心（CDC）向美国心臟协会津贴840万美元，用于开展一项以心臟瓣膜疾病教育为重点的全国性宣传活动。这些倡议包括针对患者、医疗保健提供者以及女性（一个服务不足的高风险群体）的教育推广。该计画源自于两党共同製定的《优先研究和宣传心臟瓣膜疾病法案》（CAROL法案），该法案于2022年12月签署生效。

与传统的开心手术相比，包括经导管瓣膜置换术(TAVR) 在内的微创手术由于恢復时间更短、併发症风险更低、整体医疗成本更低而越来越受欢迎。这种向非侵入性手术的转变是推动市场发展的关键因素。 2024 年 4 月，雅培宣布 FDA核准TriClip 系统，这是一种用于治疗瓣膜闭锁不全(TR) 的经导管边对边修復技术。这款世界首创的装置可实现微创治疗，并改善患者预后，无需进行高风险的开心手术。临床试验表明，使用 TriClip 的患者 TR 严重程度和生活品质得到显着改善。

经导管心臟瓣膜 (THV) 设计的技术进步是推动市场成长的关键因素，包括提高瓣膜耐用性、易于植入和改善患者预后。影像处理技术和瓣膜输送系统的进步也显着提高了手术成功率，扩大了适合 THV 手术的患者群体。 2024 年 8 月，波士顿科学公司宣布其 ACURATE Prime 主动脉瓣系统获得 CE 标誌核准。这种尖端的经导管主动脉瓣置换系统采用新的瓣膜尺寸，以适应较大的患者解剖结构。它适用于患有严重主动脉瓣狭窄的低风险、中度风险和高风险患者。该系统采用自扩张设计和先进的部署机制，提高了瓣膜定位精度并改善了患者的整体预后。

目录

第一章调查方法与范围

第二章执行摘要

第三章全球人工心臟瓣膜市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 补贴市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 全球人工心臟瓣膜市场分析工具
    • 产业分析-波特五力分析
    • PESTLE分析
  • 技术格局
  • 案例研究分析

4. 全球人工心臟瓣膜市场細項分析（依瓣膜分类），2021-2033 年

  • 定义和范围
  • 2024年及2033年阀门市占率分析
  • 细分仪表板
  • 全球人工心臟瓣膜市场（按瓣膜，2021-2033 年）
  • 经导管心臟瓣膜
    • 经导管心臟瓣膜市场估计与预测（2021-2033年）
  • 生物瓣膜（组织瓣膜）
    • 生物瓣膜（组织瓣膜）市场预测与预测（2021-2033年）
    • 支架
    • 异种移植
    • 无支架
    • 同种异体移植
  • 机械阀
    • 机械瓣膜市场估计与预测（2021-2033年）
    • 斜盘阀
    • 球笼阀

5. 2021-2033 年全球人工心臟瓣膜市场細項分析（依资料）

  • 定义和范围
  • 2024年及2033年材料市占率分析
  • 细分仪表板
  • 全球人工心臟瓣膜市场（依材料划分）（2021-2033）
  • 生物组织
    • 2021-2033年生物组织市场估计与预测
  • 热解碳
    • 2021-2033年热解碳市场估计与预测
  • 金属合金
    • 2021-2033年金属合金市场估计与预测
  • 聚合物
    • 2021-2033年聚合物市场预测

6. 全球人工心臟瓣膜市场細項分析（依最终用途），2021-2033

  • 定义和范围
  • 2024年及2033年最终用途市占率分析
  • 细分仪表板
  • 2021-2033年全球人工心臟瓣膜市场（依最终用途）
  • 医院
    • 2021-2033年医院市场估计与预测
  • 门诊手术中心
    • 2021-2033年门诊手术中心市场估计与预测
  • 其他的
    • 2021-2033年其他市场估计与预测

7. 2021-2033 年人工心臟瓣膜市场細項分析（按地区）

  • 2024 年及 2034 年区域市占率分析
  • 区域市场仪表板
  • 区域市场概况
  • 2024 年及 2033 年各地区人工心臟瓣膜市场占有率：
  • 北美洲
    • 2021-2033年北美人工心臟瓣膜市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2021-2033年欧洲人工心臟瓣膜市场
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司简介
    • Edwards Lifesciences
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corp.
    • CryoLife, Inc.（now Artivion）
    • MicroPort Scientific Corp.
    • Lepu Medical Technology（Beijing）Co.,Ltd.
    • Venus Medtech（Hangzhou）Inc.
    • Foldax, Inc.
    • Meril Life Sciences
    • TTK Healthcare Limited
Product Code: GVR-4-68040-701-7

Prosthetic Heart Valve Market Summary

The global prosthetic heart valve market size was estimated at USD 9.64 billion in 2024 and is projected to reach USD 20.69 billion by 2033, growing at a CAGR of 8.7% from 2025 to 2033. Rising valvular heart diseases drive the growth of the market.

According to an NCBI article published in December 2024, recent estimates indicate that approximately 54.8 million people are affected by rheumatic heart disease (RHD), with a confidence range between 43.3 and 67.6 million. In addition, non-rheumatic calcific aortic valve disease (CAVD) impacts around 13.3 million individuals, while non-rheumatic degenerative mitral valve disease (DMVD) accounts for approximately 15.5 million cases globally. These conditions are among the leading causes of structural valve deterioration, often necessitating surgical or transcatheter valve replacement. Moreover, the high and growing prevalence of both rheumatic and degenerative valve disorders across diverse age groups and regions is a key factor propelling the expansion of the market.

The rising incidence of heart valve disorders, particularly among the elderly, is a key driver for the growing adoption of prosthetic heart valve procedures, including both surgical and transcatheter approaches. Degenerative conditions such as aortic stenosis and mitral regurgitation are becoming increasingly prevalent, prompting the need for effective interventions like prosthetic valve implants. According to the CDC article published in 2024, three in four adults in the U.S. have limited awareness of heart valve disease, with particularly low recognition among those aged 65 and older, ironically, the group most at risk. Annually, more than 5 million Americans are diagnosed with heart valve disease, and the condition is responsible for over 25,000 deaths each year. These figures underscore a pressing need for improved education, early diagnosis, and expanded access to prosthetic heart valve therapies.

Government funding and awareness campaigns fuel growth in the prosthetic heart valve industry. According to the American Heart Association, Inc., an article published in October 2024, the CDC awarded USD 8.4 million in grants to the American Heart Association to launch national campaigns focused on heart valve disease education. These initiatives will include educational outreach targeting patients, healthcare providers, and women, an underserved high-risk group. The program stems from the bipartisan CAROL Act, signed into law in December 2022, to prioritize HVD research and awareness.

There is an increasing demand for minimally invasive surgeries, including transcatheter valve replacement (TAVR), due to their shorter recovery times, reduced complication risks, and lower overall healthcare costs than traditional open-heart surgery. This shift towards non-invasive procedures is a critical factor propelling the market. In April 2024, Abbott announced FDA approval for its TriClip system, a transcatheter edge-to-edge repair technology for treating tricuspid regurgitation (TR). This first-of-its-kind device allows for less invasive treatment, improving patient outcomes without needing high-risk open-heart surgery. Clinical trials showed significant improvements in TR severity and quality of life for patients treated with TriClip.

Technological advancements in Transcatheter Heart Valves (THV) design, such as enhanced valve durability, ease of implantation, and better patient outcomes, are key drivers driving market growth. Advancements in imaging techniques and valve delivery systems also significantly improve procedural success and expand the patient pool eligible for THV procedures. In August 2024, Boston Scientific announced that its ACURATE Prime Aortic Valve System received CE mark approval. This state-of-the-art transcatheter aortic valve replacement system features a new valve size to serve patients with larger anatomies. It is indicated for individuals at low, intermediate, and high risk experiencing severe aortic stenosis. The system incorporates a self-expanding design and a refined deployment mechanism, enhancing valve positioning accuracy to improve overall patient outcomes.

Global Prosthetic Heart Valve Market Report Segmentation

This report forecasts revenue growth and analyzes the latest trends in each sub-segments from 2021 to 2033 at the global, regional, and country levels. For this report, Grand View Research has segmented the global prosthetic heart valve market report based on valve, material, end-use, and region:

  • Valve Outlook (Revenue, USD Million, 2021 - 2033)
  • Transcatheter Heart Valves
  • Bioprosthetic (Tissue) Valves
  • Homograft's
    • Heterografts
    • Stented
    • Stentless
  • Mechanical Valves
    • Tilting Disc Valves
    • Ball Cage Valves
  • Material Outlook (Revenue, USD Million, 2021 - 2033)
  • Metal Alloys
  • Pyrolytic Carbon
  • Biological Tissue
  • Polymers
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Valve outlook
    • 2.2.2. End Use outlook
  • 2.3. Competitive Insights

Chapter 3. Global Prosthetic Heart Valve Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising valvular heart diseases
      • 3.2.1.2. Government funding and awareness campaigns
      • 3.2.1.3. Technological advancements in heart valve
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatments
      • 3.2.2.2. Regulatory challenges and approval delays
  • 3.3. Global Prosthetic Heart Valve: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Technology Landscape
  • 3.5. Case Study Analysis

Chapter 4. Global Prosthetic Heart Valve Market Segment Analysis, By Valve, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Valve Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Prosthetic Heart Valve Market, by Valve, 2021 to 2033
  • 4.5. Transcatheter Heart Valves
    • 4.5.1. Transcatheter heart valves market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Bioprosthetic (Tissue) Valves
    • 4.6.1. Bioprosthetic (Tissue) valves market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.2. Stented
      • 4.6.2.1. Stented market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.3. Heterografts
      • 4.6.3.1. Heterografts market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.4. Stentless
      • 4.6.4.1. Stentless market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.5. Homografts
      • 4.6.5.1. Homografts market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7. Mechanical Valves
    • 4.7.1. Mechanical valves market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.7.2. Tilting Disc Valves
      • 4.7.2.1. Tilting disc valves market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.7.2.1.1. CRT-Defibrillator
        • 4.7.2.1.2. CRT-Pacemakers
    • 4.7.3. Ball Cage Valves
      • 4.7.3.1. Ball cage valves market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Global Prosthetic Heart Valve Market Segment Analysis, By Material, 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Material Market Share Analysis, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Prosthetic Heart Valve Market, by Material, 2021 to 2033
  • 5.5. Biological Tissue
    • 5.5.1. Biological tissue market estimates and forecasts, 2021 to 2033 (USD million)
  • 5.6. Pyrolytic Carbon
    • 5.6.1. Pyrolytic carbon market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Metal Alloys
    • 5.7.1. Metal alloys market estimates and forecasts, 2021 to 2033 (USD million)
  • 5.8. Polymers
    • 5.8.1. Polymers market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Global Prosthetic Heart Valve Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2024 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Global Prosthetic Heart Valve Market, by End Use, 2021 to 2033
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD million)
  • 6.6. Ambulatory Surgery Centers
    • 6.6.1. Ambulatory surgery centers market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts, 2021 to 2033 (USD million)

Chapter 7. Prosthetic Heart Valve Market Segment Analysis, By Region, 2021- 2033 (USD Million)

  • 7.1. Regional Market Share Analysis, 2024 & 2034
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Prosthetic Heart Valve Market Share by Region, 2024 & 2033:
  • 7.5. North America
    • 7.5.1. North America prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Scenario
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. U.S. prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Scenario
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Canada prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Scenario
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Mexico prosthetic heart valve market, 2021 - 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Scenario
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. UK prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Scenario
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Germany prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Scenario
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. France prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Scenario
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Italy prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Scenario
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Spain prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Scenario
      • 7.6.7.3. Competitive Scenario
      • 7.6.7.4. Norway prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Regulatory Scenario
      • 7.6.8.3. Competitive Scenario
      • 7.6.8.4. Sweden prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Key Country Dynamics
      • 7.6.9.2. Regulatory Scenario
      • 7.6.9.3. Competitive Scenario
      • 7.6.9.4. Denmark prosthetic heart valve market, 2021 - 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Scenario
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Japan prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Scenario
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. China prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Scenario
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. India prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Regulatory Scenario
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Australia prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Regulatory Scenario
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. South Korea prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Regulatory Scenario
      • 7.7.6.3. Competitive Scenario
      • 7.7.6.4. Thailand prosthetic heart valve market, 2021 - 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Scenario
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. Brazil prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Scenario
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Argentina prosthetic heart valve market, 2021 - 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key Country Dynamics
      • 7.9.1.2. Regulatory Scenario
      • 7.9.1.3. Competitive Scenario
      • 7.9.1.4. South Africa prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Regulatory Scenario
      • 7.9.2.3. Competitive Scenario
      • 7.9.2.4. Saudi Arabia prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Regulatory Scenario
      • 7.9.3.3. Competitive Scenario
      • 7.9.3.4. UAE prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Regulatory Scenario
      • 7.9.4.3. Competitive Scenario
      • 7.9.4.4. Kuwait prosthetic heart valve market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Profiles
    • 8.3.1. Edwards Lifesciences
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Valve benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Medtronic plc
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Valve benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Abbott Laboratories
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Valve benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Boston Scientific Corp.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Valve benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. CryoLife, Inc. (now Artivion)
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Valve benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. MicroPort Scientific Corp.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Valve benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Lepu Medical Technology(Beijing)Co.,Ltd.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Valve benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Venus Medtech (Hangzhou) Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Valve benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Foldax, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Valve benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Meril Life Sciences
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Valve benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. TTK Healthcare Limited
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Valve benchmarking
      • 8.3.11.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 4. Global Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 5. Global Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 6. Global Prosthetic Heart Valve Market, By Region, 2021 - 2033 (USD Million)
  • Table 7. North America Prosthetic Heart Valve Market, By Country, 2021 - 2033 (USD Million)
  • Table 8. North America Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 9. North America Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 10. North America Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 11. U.S. Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 12. U.S. Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 13. U.S. Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 14. Canada Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 15. Canada Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 16. Canada Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17. Mexico Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 18. Mexico Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 19. Mexico Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 20. Europe Prosthetic Heart Valve Market, By Country, 2021 - 2033 (USD Million)
  • Table 21. Europe Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 22. Europe Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 23. Europe Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 24. UK Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 25. UK Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 26. UK Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 27. Germany Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 28. Germany Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 29. Germany Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30. France Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 31. France Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 32. France Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 33. Italy Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 34. Italy Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 35. Italy Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 36. Spain Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 37. Spain Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 38. Spain Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 39. Denmark Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 40. Denmark Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 41. Denmark Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42. Sweden Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 43. Sweden Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 44. Sweden Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 45. Norway Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 46. Norway Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 47. Norway Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific Prosthetic Heart Valve Market, by Country, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 50. Asia Pacific Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 51. Asia Pacific Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 52. Japan Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 53. Japan Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 54. Japan Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 55. China Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 56. China Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 57. China Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58. India Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 59. India Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 60. India Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 61. Australia Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 62. Australia Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 63. Australia Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 64. Thailand Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 65. Thailand Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 66. Thailand Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67. South Korea Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 68. South Korea Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 69. South Korea Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 70. Latin America Prosthetic Heart Valve Market, by Country, 2021 - 2033 (USD Million)
  • Table 71. Latin America Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 72. Latin America Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 73. Latin America Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 74. Brazil Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 75. Brazil Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 76. Brazil Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 77. Argentina Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 78. Argentina Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 79. Argentina Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 80. Middle East & Africa Prosthetic Heart Valve Market, by Country, 2021 - 2033 (USD Million)
  • Table 81. Middle East & Africa Prosthetic Heart Valve Market, by Valve, 2021 - 2033 (USD Million)
  • Table 82. Middle East & Africa Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 83. Middle East & Africa Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 84. South Africa Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 85. South Africa Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 86. South Africa Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 89. Saudi Arabia Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 90. UAE Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 91. UAE Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 92. UAE Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 93. Kuwait Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 94. Kuwait Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 95. Kuwait Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Global prosthetic heart valve market: outlook
  • Fig. 9 Global prosthetic heart valve competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Ancillary market outlook
  • Fig. 12 Global prosthetic heart valve market driver impact
  • Fig. 13 Global prosthetic heart valve market restraint impact
  • Fig. 14 Porter's Analysis
  • Fig. 15 PESTLE Analysis
  • Fig. 16 Global prosthetic heart valve market: Valve movement analysis
  • Fig. 17 Global prosthetic heart valve market: Valve outlook and key takeaways
  • Fig. 18 Transcatheter heart valves market estimates and forecast, 2021 - 2033
  • Fig. 19 Bioprosthetic (Tissue) valves market estimates and forecast, 2021 - 2033
  • Fig. 20 Stented market estimates and forecast, 2021 - 2033
  • Fig. 21 Heterografts market estimates and forecast, 2021 - 2033
  • Fig. 22 Stentless market estimates and forecast, 2021 - 2033
  • Fig. 23 Homografts market estimates and forecast, 2021 - 2033
  • Fig. 24 Mechanical valves market estimates and forecast, 2021 - 2033
  • Fig. 25 Tilting disc valves market estimates and forecast, 2021 - 2033
  • Fig. 26 Ball cage valves market estimates and forecast, 2021 - 2033
  • Fig. 27 Global prosthetic heart valve market: Material movement analysis
  • Fig. 28 Global prosthetic heart valve market: Material outlook and key takeaways
  • Fig. 29 Metal alloys market estimates and forecasts, 2021 - 2033
  • Fig. 30 Pyrolytic carbon market estimates and forecasts,2021 - 2033
  • Fig. 31 Biological tissue market estimates and forecasts,2021 - 2033
  • Fig. 32 Polymers market estimates and forecasts,2021 - 2033
  • Fig. 33 Global prosthetic heart valve market: End Use movement analysis
  • Fig. 34 Global prosthetic heart valve market: End Use outlook and key takeaways
  • Fig. 35 Hospitals market estimates and forecasts, 2021 - 2033
  • Fig. 36 Ambulatory Surgical Centers (ASCs) market estimates and forecasts,2021 - 2033
  • Fig. 37 Others market estimates and forecasts,2021 - 2033
  • Fig. 38 Polymers market estimates and forecasts,2021 - 2033
  • Fig. 39 Global prosthetic heart valve market: Regional outlook and key takeaways
  • Fig. 40 North America prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 U.S. prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Canada prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Mexico prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Europe prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 UK prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Germany prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Spain prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 France prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Italy prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Norway prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Denmark prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Sweden prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Asia Pacific prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Japan prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 China prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 India prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Australia prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 South Korea prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Thailand prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Latin America prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Brazil prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Argentina prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 MEA prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 South Africa prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Saudi Arabia prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 UAE prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Kuwait prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key company categorization
  • Fig. 92 Heat map analysis 2024